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Caring for older people is now the predominant activity of health systems in high-income countries, 
and will soon become the predominant activity in many lower and middle income countries [1]. At 
present there is a mismatch between the scale of healthcare need for older people, and the 
relatively modest amount of research funding and activity in this area which is holding back much-
needed innovation. A number of initiatives have aimed to redress the balance - in Europe for 
example the Increasing Participation of the Elderly in Clinical Trials (PREDICT) consortium studied the 
participation of older people in clinical trials and proposed ways of boosting recruitment [2]. In the 
UK in 2017-18, over 22,000 older people were recruited to studies on the National Institute of Health 
Research (NIHR) Clinical Research Network portfolio, but only 7,000 were recruited to studies 
primarily categorised under Ageing; the number of clinical studies primarily categorised under 
Ageing on the NIHR portfolio [3] is 29% and 16% of the number for respiratory medicine and 
cardiovascular medicine respectively. 
 
Why might this be, and what can we do about it? These questions were considered by a group of UK 
research-active geriatricians in March 2018, gathered under the auspices of the NIHR Newcastle 
Biomedical Research Centre, UK - which has a particular focus on ageing and long-term conditions. 
Invited senior investigators, trainees and PhD candidates met for an intensive one-day meeting, and 
this commentary describes some potential solutions generated by the group. 
 
What are the problems? 
The first problem is one of capacity. There are few research-active clinicians compared to the 
volume of clinical activity; this shortage is evident for academic nurses and allied healthcare 
professionals (AHPs) in the field as well as doctors. Research work in geriatric medicine is vital for 
patients and society, but may not always translate into the metrics by which universities value and 
appoint staff, such as reports in journals with a high impact factor. Lack of visibility may contribute 
to academically inclined trainees not perceiving geriatric medicine as a research-active specialty to 
pursue, and consequently diverting into other specialities. 
 
The second problem is one of culture. There is a perception amongst some clinicians that geriatric 
medicine is not a speciality that needs to do research – a view perhaps driven by the problems 
outlined above. Research is too often seen as distant from practice, findings are not effectively 
disseminated or embedded into teaching or care, and the research agenda is not always perceived 
to align with the priorities of patients, policymakers or clinicians. 
 
The third problem is a failure of translation. Much ageing research is done in discovery science, but 
with few clinicians directly involved this work has had little impact on patient care to date. Similarly, 
at practice level, geriatric medicine is constantly innovating and developing new models of service, 
yet little rigorous evaluation takes place. Much of the research that is conducted lacks the scale or 
impact to influence practice. 
 
What then might the solutions be? The meeting considered four major areas of activity, which we 
outline below: 
 
a) Involving clinicians in research 
Clinical research at scale requires recruitment at multiple sites, many of which may not be affiliated 
to universities. Hence we need to ensure that all clinicians can be active in research; such an 
approach is also likely to facilitate implementation of findings. In the UK, the NIHR CRN Ageing 
Speciality Group and parallel structures in the devolved nations assist this process by providing 
infrastructure support for clinical ageing research delivery. Involvement in research by early career 
staff across all professions would develop a larger group representative of those delivering care who 
are familiar with research processes such as recruiting to clinical trials; a spin-off benefit would be 
enhanced awareness of, and skills to interpret, research evidence. Support networks have been 
successful in supporting clinicians to engage with research in some disease areas, such as stroke, 
Parkinson’s, dementia, and osteoporosis – and in delivering focussed training for clinicians to 
support research activity. The challenge is to ensure that ageing syndromes and a wider range of 
disease areas are represented. 
 
Funding is necessary either to support research time directly, or to allow cover for research time by 
others. Although mechanisms in the UK do exist to allow funds to ‘follow the participant’, service 
pressures often make it difficult to release time even when funds allow. In healthcare systems where 
private practice or clinician-level billing are prevalent, funding is essential to make research activity 
an attractive and viable alternative to service delivery.  
 
b) Developing early-career researchers 
The decision to specialise in geriatric medicine is made relatively late compared to some specialities 
[4,5]. Academics focussing on ageing and the care of older people are in competition with these 
other specialities – for fellowships, awards and for university tenure. Furthermore, they do not 
typically have access to the considerable funding resources of, for example, the major cardiovascular 
health and oncology research charities for early career support. Any successful approach to building 
capacity therefore has to start early. The pipeline of trained investigators could be strengthened by 
enhancing the visibility of the speciality in undergraduate medical, nursing and AHP education; 
offering undergraduate research projects relevant to ageing, and providing research training for very 
early-career practitioners. The resulting candidates would have better awareness and experience, 
and be competitive for higher research training at PhD level. Expanding the numbers of PhD posts 
relevant to translational ageing research is necessary, but is unlikely to be sufficient. 
 
The transition from PhD to independent researcher remains a major challenge in many scientific 
disciplines [6]. Good mentorship for academics at this career stage is critical to drive successful 
intermediate fellowship bids; models such as the establishment of an Ageing Academy or School for 
Ageing Research may be required to deliver this support. Representation of geriatric medicine on 
selection panels is also necessary to provide relevant expertise for funding decisions, taking into 
account the often highly complex mechanisms and pathways involved in ageing biology and 
common geriatric syndromes. 
 
c) Getting research into clinical practice 
Bridging the ‘know-do’ gap [7,8] is essential if research benefits are to reach patients. Choosing 
appropriate research questions is important, and the James Lind Alliance on priority-setting for 
research is an excellent model for this [9]; the alliance has recently published the top ten priorities 
for research for people with multiple conditions [10]. Co-production of research by knowledge users 
and research teams helps to ensure that the results will be relevant to both clinicians and patients. 
Embedding assessment of implementation strategies (in particular areas of implementation failure 
including cost, training and workflow) is another key component, as is the use of linked, routinely 
collected health and social care data to evaluate interventions in real-world populations. Co-
production can also help with dissemination - targeting research findings to research users in ways 
that they find useful. Research users need to be ready to receive and engage with research findings; 
this can be facilitated by delivering research findings that are both relevant and accessible to 
practitioners. In the UK the applied healthcare research programmes of several regional NIHR 
Collaborations for Leadership in Applied Health Research and Care (CLAHRCs) seek to address this 
translational gap. 
 
d) Expanding the funding envelope 
There is growing awareness of the importance of ageing and care of older people by funders. 
European Union funding streams have included a substantial component of research which is 
directly relevant for older people. Within the UK, the recent Academy of Medical Sciences report on 
multimorbidity [11] presages increased interest from a range of funders in this area. In his 2017 
Harveian Oration [12], Professor Chris Whitty, Head of NIHR and Chief Scientific Advisor for the UK 
Department of Health and Social Care, spoke of the urgent need to focus on the health of older 
people, particularly those with multiple conditions, and of the need to drastically increase the 
capacity of the research community to tackle the health problems of old age. If these funding 
streams are to fully benefit older people, academic geriatricians need to drive multidisciplinary, 
multicentre bids to address key research questions at scale and pace, as well as providing 
representation on the funding panels that consider such bids. 
 
There is also scope to widen our funding sources. In the UK, individual philanthropy is relatively 
under-used compared to the USA, and industry is not currently a major funding source – although 
care is needed to ensure high-quality science and to avoid conflicts of interest and intellectual 
property. As instinctive collaborators used to working in multidisciplinary clinical teams, geriatricians 
are well placed to exploit the current interest in interdisciplinary funding, as well as working with 
other specialists in accessing funding from organ-specific charities.  In the US there is a dedicated 
National Institute on Aging (NIA). Opportunities exist for international collaborative work accessing 
NIA funds via partnering with US colleagues, even with current budgetary pressures [13] 
 
In summary, growing research in geriatric medicine and interdisciplinary gerontology is an essential 
component of improving healthcare for older people. This is now being prioritised by governments 
and funders. There has never been a more opportune time to demonstrate that as a community we 
can bring academic and clinical activity together to provide better care for our patients. We must be 
both innovative and bold in developing capacity to deliver research into practice – our patients 
deserve no less. 
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